Table of Content

1 Study Coverage
1.1 Oncology Radiopharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Radiopharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral Drugs
1.2.3 Intravenous Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Oncology Radiopharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical Company
1.3.4 Research Center
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oncology Radiopharmaceutical Sales Estimates and Forecasts 2018-2034
2.2 Global Oncology Radiopharmaceutical Revenue by Region
2.2.1 Global Oncology Radiopharmaceutical Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Oncology Radiopharmaceutical Revenue by Region (2018-2024)
2.2.3 Global Oncology Radiopharmaceutical Revenue by Region (2024-2034)
2.2.4 Global Oncology Radiopharmaceutical Revenue Market Share by Region (2018-2034)
2.3 Global Oncology Radiopharmaceutical Sales Estimates and Forecasts 2018-2034
2.4 Global Oncology Radiopharmaceutical Sales by Region
2.4.1 Global Oncology Radiopharmaceutical Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Oncology Radiopharmaceutical Sales by Region (2018-2024)
2.4.3 Global Oncology Radiopharmaceutical Sales by Region (2024-2034)
2.4.4 Global Oncology Radiopharmaceutical Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Oncology Radiopharmaceutical Sales by Manufacturers
3.1.1 Global Oncology Radiopharmaceutical Sales by Manufacturers (2018-2024)
3.1.2 Global Oncology Radiopharmaceutical Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology Radiopharmaceutical in 2022
3.2 Global Oncology Radiopharmaceutical Revenue by Manufacturers
3.2.1 Global Oncology Radiopharmaceutical Revenue by Manufacturers (2018-2024)
3.2.2 Global Oncology Radiopharmaceutical Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oncology Radiopharmaceutical Revenue in 2022
3.3 Global Key Players of Oncology Radiopharmaceutical, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Oncology Radiopharmaceutical Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oncology Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oncology Radiopharmaceutical, Product Offered and Application
3.8 Global Key Manufacturers of Oncology Radiopharmaceutical, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology Radiopharmaceutical Sales by Type
4.1.1 Global Oncology Radiopharmaceutical Historical Sales by Type (2018-2024)
4.1.2 Global Oncology Radiopharmaceutical Forecasted Sales by Type (2024-2034)
4.1.3 Global Oncology Radiopharmaceutical Sales Market Share by Type (2018-2034)
4.2 Global Oncology Radiopharmaceutical Revenue by Type
4.2.1 Global Oncology Radiopharmaceutical Historical Revenue by Type (2018-2024)
4.2.2 Global Oncology Radiopharmaceutical Forecasted Revenue by Type (2024-2034)
4.2.3 Global Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2034)
4.3 Global Oncology Radiopharmaceutical Price by Type
4.3.1 Global Oncology Radiopharmaceutical Price by Type (2018-2024)
4.3.2 Global Oncology Radiopharmaceutical Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Oncology Radiopharmaceutical Sales by Application
5.1.1 Global Oncology Radiopharmaceutical Historical Sales by Application (2018-2024)
5.1.2 Global Oncology Radiopharmaceutical Forecasted Sales by Application (2024-2034)
5.1.3 Global Oncology Radiopharmaceutical Sales Market Share by Application (2018-2034)
5.2 Global Oncology Radiopharmaceutical Revenue by Application
5.2.1 Global Oncology Radiopharmaceutical Historical Revenue by Application (2018-2024)
5.2.2 Global Oncology Radiopharmaceutical Forecasted Revenue by Application (2024-2034)
5.2.3 Global Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2034)
5.3 Global Oncology Radiopharmaceutical Price by Application
5.3.1 Global Oncology Radiopharmaceutical Price by Application (2018-2024)
5.3.2 Global Oncology Radiopharmaceutical Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Oncology Radiopharmaceutical Market Size by Type
6.1.1 US & Canada Oncology Radiopharmaceutical Sales by Type (2018-2034)
6.1.2 US & Canada Oncology Radiopharmaceutical Revenue by Type (2018-2034)
6.2 US & Canada Oncology Radiopharmaceutical Market Size by Application
6.2.1 US & Canada Oncology Radiopharmaceutical Sales by Application (2018-2034)
6.2.2 US & Canada Oncology Radiopharmaceutical Revenue by Application (2018-2034)
6.3 US & Canada Oncology Radiopharmaceutical Market Size by Country
6.3.1 US & Canada Oncology Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Oncology Radiopharmaceutical Sales by Country (2018-2034)
6.3.3 US & Canada Oncology Radiopharmaceutical Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Oncology Radiopharmaceutical Market Size by Type
7.1.1 Europe Oncology Radiopharmaceutical Sales by Type (2018-2034)
7.1.2 Europe Oncology Radiopharmaceutical Revenue by Type (2018-2034)
7.2 Europe Oncology Radiopharmaceutical Market Size by Application
7.2.1 Europe Oncology Radiopharmaceutical Sales by Application (2018-2034)
7.2.2 Europe Oncology Radiopharmaceutical Revenue by Application (2018-2034)
7.3 Europe Oncology Radiopharmaceutical Market Size by Country
7.3.1 Europe Oncology Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Oncology Radiopharmaceutical Sales by Country (2018-2034)
7.3.3 Europe Oncology Radiopharmaceutical Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Oncology Radiopharmaceutical Market Size
8.1.1 China Oncology Radiopharmaceutical Sales (2018-2034)
8.1.2 China Oncology Radiopharmaceutical Revenue (2018-2034)
8.2 China Oncology Radiopharmaceutical Market Size by Application
8.2.1 China Oncology Radiopharmaceutical Sales by Application (2018-2034)
8.2.2 China Oncology Radiopharmaceutical Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Oncology Radiopharmaceutical Market Size by Type
9.1.1 Asia Oncology Radiopharmaceutical Sales by Type (2018-2034)
9.1.2 Asia Oncology Radiopharmaceutical Revenue by Type (2018-2034)
9.2 Asia Oncology Radiopharmaceutical Market Size by Application
9.2.1 Asia Oncology Radiopharmaceutical Sales by Application (2018-2034)
9.2.2 Asia Oncology Radiopharmaceutical Revenue by Application (2018-2034)
9.3 Asia Oncology Radiopharmaceutical Sales by Region
9.3.1 Asia Oncology Radiopharmaceutical Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Oncology Radiopharmaceutical Revenue by Region (2018-2034)
9.3.3 Asia Oncology Radiopharmaceutical Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oncology Radiopharmaceutical Market Size by Type
10.1.1 Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Oncology Radiopharmaceutical Market Size by Application
10.2.1 Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Country
10.3.1 Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Chimeric Therapeutics Limited
11.2.1 Chimeric Therapeutics Limited Company Information
11.2.2 Chimeric Therapeutics Limited Overview
11.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chimeric Therapeutics Limited Recent Developments
11.3 Fusion Pharma
11.3.1 Fusion Pharma Company Information
11.3.2 Fusion Pharma Overview
11.3.3 Fusion Pharma Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Fusion Pharma Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fusion Pharma Recent Developments
11.4 Lantheus Medical lmaging, Inc.
11.4.1 Lantheus Medical lmaging, Inc. Company Information
11.4.2 Lantheus Medical lmaging, Inc. Overview
11.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lantheus Medical lmaging, Inc. Recent Developments
11.5 NanoMab
11.5.1 NanoMab Company Information
11.5.2 NanoMab Overview
11.5.3 NanoMab Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 NanoMab Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 NanoMab Recent Developments
11.6 NuView Life Sciences.
11.6.1 NuView Life Sciences. Company Information
11.6.2 NuView Life Sciences. Overview
11.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 NuView Life Sciences. Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 NuView Life Sciences. Recent Developments
11.7 PentixaPharm GmbHPrecirix
11.7.1 PentixaPharm GmbHPrecirix Company Information
11.7.2 PentixaPharm GmbHPrecirix Overview
11.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PentixaPharm GmbHPrecirix Recent Developments
11.8 RadioMedix
11.8.1 RadioMedix Company Information
11.8.2 RadioMedix Overview
11.8.3 RadioMedix Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 RadioMedix Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 RadioMedix Recent Developments
11.9 RayzeBio
11.9.1 RayzeBio Company Information
11.9.2 RayzeBio Overview
11.9.3 RayzeBio Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 RayzeBio Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 RayzeBio Recent Developments
11.10 Telix Pharmaceuticals Limited
11.10.1 Telix Pharmaceuticals Limited Company Information
11.10.2 Telix Pharmaceuticals Limited Overview
11.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Telix Pharmaceuticals Limited Recent Developments
11.11 Theragnostics Ltd
11.11.1 Theragnostics Ltd Company Information
11.11.2 Theragnostics Ltd Overview
11.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Theragnostics Ltd Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Theragnostics Ltd Recent Developments
11.12 Vect-Horus
11.12.1 Vect-Horus Company Information
11.12.2 Vect-Horus Overview
11.12.3 Vect-Horus Oncology Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Vect-Horus Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Vect-Horus Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology Radiopharmaceutical Industry Chain Analysis
12.2 Oncology Radiopharmaceutical Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology Radiopharmaceutical Production Mode & Process
12.4 Oncology Radiopharmaceutical Sales and Marketing
12.4.1 Oncology Radiopharmaceutical Sales Channels
12.4.2 Oncology Radiopharmaceutical Distributors
12.5 Oncology Radiopharmaceutical Customers
13 Market Dynamics
13.1 Oncology Radiopharmaceutical Industry Trends
13.2 Oncology Radiopharmaceutical Market Drivers
13.3 Oncology Radiopharmaceutical Market Challenges
13.4 Oncology Radiopharmaceutical Market Restraints
14 Key Findings in The Global Oncology Radiopharmaceutical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oncology Radiopharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oral Drugs
Table 3. Major Manufacturers of Intravenous Drugs
Table 4. Major Manufacturers of Other
Table 5. Global Oncology Radiopharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Oncology Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Oncology Radiopharmaceutical Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Oncology Radiopharmaceutical Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Oncology Radiopharmaceutical Revenue Market Share by Region (2018-2024)
Table 10. Global Oncology Radiopharmaceutical Revenue Market Share by Region (2024-2034)
Table 11. Global Oncology Radiopharmaceutical Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 12. Global Oncology Radiopharmaceutical Sales by Region (2018-2024) & (K Units)
Table 13. Global Oncology Radiopharmaceutical Sales by Region (2024-2034) & (K Units)
Table 14. Global Oncology Radiopharmaceutical Sales Market Share by Region (2018-2024)
Table 15. Global Oncology Radiopharmaceutical Sales Market Share by Region (2024-2034)
Table 16. Global Oncology Radiopharmaceutical Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Oncology Radiopharmaceutical Sales Share by Manufacturers (2018-2024)
Table 18. Global Oncology Radiopharmaceutical Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Oncology Radiopharmaceutical Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Oncology Radiopharmaceutical, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Oncology Radiopharmaceutical Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Oncology Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Oncology Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Radiopharmaceutical as of 2022)
Table 24. Global Key Manufacturers of Oncology Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Oncology Radiopharmaceutical, Product Offered and Application
Table 26. Global Key Manufacturers of Oncology Radiopharmaceutical, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Oncology Radiopharmaceutical Sales by Type (2018-2024) & (K Units)
Table 29. Global Oncology Radiopharmaceutical Sales by Type (2024-2034) & (K Units)
Table 30. Global Oncology Radiopharmaceutical Sales Share by Type (2018-2024)
Table 31. Global Oncology Radiopharmaceutical Sales Share by Type (2024-2034)
Table 32. Global Oncology Radiopharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Oncology Radiopharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Oncology Radiopharmaceutical Revenue Share by Type (2018-2024)
Table 35. Global Oncology Radiopharmaceutical Revenue Share by Type (2024-2034)
Table 36. Oncology Radiopharmaceutical Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Oncology Radiopharmaceutical Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Oncology Radiopharmaceutical Sales by Application (2018-2024) & (K Units)
Table 39. Global Oncology Radiopharmaceutical Sales by Application (2024-2034) & (K Units)
Table 40. Global Oncology Radiopharmaceutical Sales Share by Application (2018-2024)
Table 41. Global Oncology Radiopharmaceutical Sales Share by Application (2024-2034)
Table 42. Global Oncology Radiopharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Oncology Radiopharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Oncology Radiopharmaceutical Revenue Share by Application (2018-2024)
Table 45. Global Oncology Radiopharmaceutical Revenue Share by Application (2024-2034)
Table 46. Oncology Radiopharmaceutical Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Oncology Radiopharmaceutical Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. US & Canada Oncology Radiopharmaceutical Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Oncology Radiopharmaceutical Sales by Type (2024-2034) & (K Units)
Table 50. US & Canada Oncology Radiopharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Oncology Radiopharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 52. US & Canada Oncology Radiopharmaceutical Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Oncology Radiopharmaceutical Sales by Application (2024-2034) & (K Units)
Table 54. US & Canada Oncology Radiopharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Oncology Radiopharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 56. US & Canada Oncology Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 57. US & Canada Oncology Radiopharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Oncology Radiopharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 59. US & Canada Oncology Radiopharmaceutical Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Oncology Radiopharmaceutical Sales by Country (2024-2034) & (K Units)
Table 61. Europe Oncology Radiopharmaceutical Sales by Type (2018-2024) & (K Units)
Table 62. Europe Oncology Radiopharmaceutical Sales by Type (2024-2034) & (K Units)
Table 63. Europe Oncology Radiopharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Oncology Radiopharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 65. Europe Oncology Radiopharmaceutical Sales by Application (2018-2024) & (K Units)
Table 66. Europe Oncology Radiopharmaceutical Sales by Application (2024-2034) & (K Units)
Table 67. Europe Oncology Radiopharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Oncology Radiopharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 69. Europe Oncology Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 70. Europe Oncology Radiopharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Oncology Radiopharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 72. Europe Oncology Radiopharmaceutical Sales by Country (2018-2024) & (K Units)
Table 73. Europe Oncology Radiopharmaceutical Sales by Country (2024-2034) & (K Units)
Table 74. China Oncology Radiopharmaceutical Sales by Type (2018-2024) & (K Units)
Table 75. China Oncology Radiopharmaceutical Sales by Type (2024-2034) & (K Units)
Table 76. China Oncology Radiopharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Oncology Radiopharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 78. China Oncology Radiopharmaceutical Sales by Application (2018-2024) & (K Units)
Table 79. China Oncology Radiopharmaceutical Sales by Application (2024-2034) & (K Units)
Table 80. China Oncology Radiopharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Oncology Radiopharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 82. Asia Oncology Radiopharmaceutical Sales by Type (2018-2024) & (K Units)
Table 83. Asia Oncology Radiopharmaceutical Sales by Type (2024-2034) & (K Units)
Table 84. Asia Oncology Radiopharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Oncology Radiopharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 86. Asia Oncology Radiopharmaceutical Sales by Application (2018-2024) & (K Units)
Table 87. Asia Oncology Radiopharmaceutical Sales by Application (2024-2034) & (K Units)
Table 88. Asia Oncology Radiopharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Oncology Radiopharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 90. Asia Oncology Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 91. Asia Oncology Radiopharmaceutical Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Oncology Radiopharmaceutical Revenue by Region (2024-2034) & (US$ Million)
Table 93. Asia Oncology Radiopharmaceutical Sales by Region (2018-2024) & (K Units)
Table 94. Asia Oncology Radiopharmaceutical Sales by Region (2024-2034) & (K Units)
Table 95. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Type (2024-2034) & (K Units)
Table 97. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 99. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Application (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 104. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 106. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales by Country (2024-2034) & (K Units)
Table 108. Novartis Company Information
Table 109. Novartis Description and Major Businesses
Table 110. Novartis Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Novartis Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Novartis Recent Developments
Table 113. Chimeric Therapeutics Limited Company Information
Table 114. Chimeric Therapeutics Limited Description and Major Businesses
Table 115. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Chimeric Therapeutics Limited Recent Developments
Table 118. Fusion Pharma Company Information
Table 119. Fusion Pharma Description and Major Businesses
Table 120. Fusion Pharma Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Fusion Pharma Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Fusion Pharma Recent Developments
Table 123. Lantheus Medical lmaging, Inc. Company Information
Table 124. Lantheus Medical lmaging, Inc. Description and Major Businesses
Table 125. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Lantheus Medical lmaging, Inc. Recent Developments
Table 128. NanoMab Company Information
Table 129. NanoMab Description and Major Businesses
Table 130. NanoMab Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. NanoMab Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. NanoMab Recent Developments
Table 133. NuView Life Sciences. Company Information
Table 134. NuView Life Sciences. Description and Major Businesses
Table 135. NuView Life Sciences. Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. NuView Life Sciences. Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. NuView Life Sciences. Recent Developments
Table 138. PentixaPharm GmbHPrecirix Company Information
Table 139. PentixaPharm GmbHPrecirix Description and Major Businesses
Table 140. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. PentixaPharm GmbHPrecirix Recent Developments
Table 143. RadioMedix Company Information
Table 144. RadioMedix Description and Major Businesses
Table 145. RadioMedix Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. RadioMedix Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. RadioMedix Recent Developments
Table 148. RayzeBio Company Information
Table 149. RayzeBio Description and Major Businesses
Table 150. RayzeBio Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. RayzeBio Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. RayzeBio Recent Developments
Table 153. Telix Pharmaceuticals Limited Company Information
Table 154. Telix Pharmaceuticals Limited Description and Major Businesses
Table 155. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Telix Pharmaceuticals Limited Recent Developments
Table 158. Theragnostics Ltd Company Information
Table 159. Theragnostics Ltd Description and Major Businesses
Table 160. Theragnostics Ltd Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Theragnostics Ltd Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Theragnostics Ltd Recent Developments
Table 163. Vect-Horus Company Information
Table 164. Vect-Horus Description and Major Businesses
Table 165. Vect-Horus Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Vect-Horus Oncology Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Vect-Horus Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Oncology Radiopharmaceutical Distributors List
Table 171. Oncology Radiopharmaceutical Customers List
Table 172. Oncology Radiopharmaceutical Market Trends
Table 173. Oncology Radiopharmaceutical Market Drivers
Table 174. Oncology Radiopharmaceutical Market Challenges
Table 175. Oncology Radiopharmaceutical Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Radiopharmaceutical Product Picture
Figure 2. Global Oncology Radiopharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oncology Radiopharmaceutical Market Share by Type in 2022 & 2034
Figure 4. Oral Drugs Product Picture
Figure 5. Intravenous Drugs Product Picture
Figure 6. Other Product Picture
Figure 7. Global Oncology Radiopharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Oncology Radiopharmaceutical Market Share by Application in 2022 & 2034
Figure 9. Hospitals and Clinics
Figure 10. Pharmaceutical Company
Figure 11. Research Center
Figure 12. Other
Figure 13. Oncology Radiopharmaceutical Report Years Considered
Figure 14. Global Oncology Radiopharmaceutical Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Oncology Radiopharmaceutical Revenue 2018-2034 (US$ Million)
Figure 16. Global Oncology Radiopharmaceutical Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Oncology Radiopharmaceutical Revenue Market Share by Region (2018-2034)
Figure 18. Global Oncology Radiopharmaceutical Sales 2018-2034 ((K Units)
Figure 19. Global Oncology Radiopharmaceutical Sales Market Share by Region (2018-2034)
Figure 20. US & Canada Oncology Radiopharmaceutical Sales YoY (2018-2034) & (K Units)
Figure 21. US & Canada Oncology Radiopharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Oncology Radiopharmaceutical Sales YoY (2018-2034) & (K Units)
Figure 23. Europe Oncology Radiopharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Oncology Radiopharmaceutical Sales YoY (2018-2034) & (K Units)
Figure 25. China Oncology Radiopharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Asia (excluding China) Oncology Radiopharmaceutical Sales YoY (2018-2034) & (K Units)
Figure 27. Asia (excluding China) Oncology Radiopharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Oncology Radiopharmaceutical Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Oncology Radiopharmaceutical in the World: Market Share by Oncology Radiopharmaceutical Revenue in 2022
Figure 32. Global Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Oncology Radiopharmaceutical Sales Market Share by Type (2018-2034)
Figure 34. Global Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2034)
Figure 35. Global Oncology Radiopharmaceutical Sales Market Share by Application (2018-2034)
Figure 36. Global Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2034)
Figure 37. US & Canada Oncology Radiopharmaceutical Sales Market Share by Type (2018-2034)
Figure 38. US & Canada Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2034)
Figure 39. US & Canada Oncology Radiopharmaceutical Sales Market Share by Application (2018-2034)
Figure 40. US & Canada Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2034)
Figure 41. US & Canada Oncology Radiopharmaceutical Revenue Share by Country (2018-2034)
Figure 42. US & Canada Oncology Radiopharmaceutical Sales Share by Country (2018-2034)
Figure 43. U.S. Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Oncology Radiopharmaceutical Sales Market Share by Type (2018-2034)
Figure 46. Europe Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2034)
Figure 47. Europe Oncology Radiopharmaceutical Sales Market Share by Application (2018-2034)
Figure 48. Europe Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2034)
Figure 49. Europe Oncology Radiopharmaceutical Revenue Share by Country (2018-2034)
Figure 50. Europe Oncology Radiopharmaceutical Sales Share by Country (2018-2034)
Figure 51. Germany Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 52. France Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 53. U.K. Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 54. Italy Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 55. Russia Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 56. China Oncology Radiopharmaceutical Sales Market Share by Type (2018-2034)
Figure 57. China Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2034)
Figure 58. China Oncology Radiopharmaceutical Sales Market Share by Application (2018-2034)
Figure 59. China Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2034)
Figure 60. Asia Oncology Radiopharmaceutical Sales Market Share by Type (2018-2034)
Figure 61. Asia Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2034)
Figure 62. Asia Oncology Radiopharmaceutical Sales Market Share by Application (2018-2034)
Figure 63. Asia Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2034)
Figure 64. Asia Oncology Radiopharmaceutical Revenue Share by Region (2018-2034)
Figure 65. Asia Oncology Radiopharmaceutical Sales Share by Region (2018-2034)
Figure 66. Japan Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 67. South Korea Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 68. China Taiwan Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 69. Southeast Asia Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 70. India Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2034)
Figure 73. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2034)
Figure 75. Middle East, Africa and Latin America Oncology Radiopharmaceutical Revenue Share by Country (2018-2034)
Figure 76. Middle East, Africa and Latin America Oncology Radiopharmaceutical Sales Share by Country (2018-2034)
Figure 77. Brazil Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 78. Mexico Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 79. Turkey Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 80. Israel Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 81. GCC Countries Oncology Radiopharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 82. Oncology Radiopharmaceutical Value Chain
Figure 83. Oncology Radiopharmaceutical Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed